Jane Street’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.4K | Sell |
61,052
-19,707
| -24% | -$22.1K | ﹤0.01% | 5051 |
|
|
2025
Q1 | $78.4K | Buy |
80,759
+67,886
| +527% | +$65.9K | ﹤0.01% | 5251 |
|
|
2024
Q4 | $15.1K | Buy |
+12,873
| New | +$15.1K | ﹤0.01% | 5643 |
|
|
2022
Q2 | – | Sell |
-52,507
| Closed | -$294K | – | 5707 |
|
|
2022
Q1 | $294K | Buy |
52,507
+24,807
| +90% | +$139K | ﹤0.01% | 4336 |
|
|
2021
Q4 | $173K | Buy |
27,700
+16,639
| +150% | +$104K | ﹤0.01% | 4464 |
|
|
2021
Q3 | $109K | Buy |
11,061
+537
| +5% | +$5.29K | ﹤0.01% | 4666 |
|
|
2021
Q2 | $94K | Sell |
10,524
-546
| -5% | -$4.88K | ﹤0.01% | 4765 |
|
|
2021
Q1 | $123K | Buy |
+11,070
| New | +$123K | ﹤0.01% | 4495 |
|
|
2020
Q4 | – | Sell |
-10,807
| Closed | -$64K | – | 3977 |
|
|
2020
Q3 | $64K | Sell |
10,807
-19,904
| -65% | -$118K | ﹤0.01% | 3534 |
|
|
2020
Q2 | $155K | Buy |
+30,711
| New | +$155K | ﹤0.01% | 3517 |
|
|
2019
Q4 | – | Sell |
-23,655
| Closed | -$632K | – | 3408 |
|
|
2019
Q3 | $632K | Buy |
+23,655
| New | +$632K | ﹤0.01% | 1961 |
|